Biotechnology Clinical Trials Coronavirus Coronavirus COVID-19 Infectious Diseases Vaccines Low-dose Administration of MERS DNA Vaccine Candidate Induces Potent Immunity and Protects From Virus Challenge in Preclinical Models By Staff Reports 6 months ago A synthetic DNA vaccine candidate for Middle East respiratory syndrome coronavirus (MERS-CoV) developed at The
age-related decline Aging Alzheimers and Dementia Behavioral Science Biotechnology Clinical Trials drug development Pharmaceuticals Potential drug for Alzheimer’s disease prevention shown to be safe and effective in animals By Staff Reports 8 months ago Researchers at the University of California San Diego School of Medicine and Massachusetts General Hospital
Biotech Company News Biotechnology Clinical Trials Coronavirus Coronavirus COVID-19 Infection Control Infectious Diseases rare diseases Vaccines Moderna’s virus vaccine shows overwhelming success in U.S. tests By Staff Reports 11 months ago Moderna said Monday its COVID-19 vaccine is proving highly effective in a major trial, a
Biotechnology cancer Immunotherapies Kidney disease kidney function decline Immunotherapy Side Effect Could Be A Positive Sign For Kidney Cancer Patients By Staff Reports 12 months ago An autoimmune side effect of immune checkpoint inhibitor (ICI) drugs could signal improved control of
Biotechnology Clinical Trials Coronavirus Coronavirus COVID-19 NIH begins large clinical trial to test immune modulators for treatment of COVID-19 By Staff Reports 12 months ago The National Institutes of Health has launched an adaptive Phase 3 clinical trial to evaluate
Biotechnology Clinical Trials Coronavirus rare diseases Vaccines Investigational COVID-19 vaccine well-tolerated, generates immune response in older adults By Staff Reports 1 year ago A Phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown
rare diseases Positive Results Reported in Study for the Treatment of Niemann-Pick disease Type C By Staff Reports 1 year ago A multinational clinical trial investigating a new treatment of Niemann-Pick disease Type C (NPC), reported
Biotechnology Centers for Disease Control Clinical Trials Coronavirus Coronavirus COVID-19 Infection Control Infectious Diseases rare diseases Vaccines Antibody responses in COVID-19 patients could guide vaccine design By Staff Reports 1 year ago A comprehensive analysis of antibody responses in coronavirus disease 2019 (COVID-19) patients could inform the
Biotechnology cancer Clinical Trials Targeted therapy combination effective for patients with advanced cholangiocarcinoma and BRAF mutations By Staff Reports 1 year ago In a Phase II trial led by researchers at The University of Texas MD Anderson
Clinical Trials Coronavirus Study finds COVID-19 convalescent plasma therapy safe, with 76% patients improving By Staff Reports 1 year ago The country’s first convalescent plasma transfusion trial results have been peer-reviewed and published, showing 19
Biotechnology Clinical Trials Coronavirus Coronavirus COVID-19 UCLA launches clinical trial to help reduce severity of COVID-19 By Staff Reports 1 year ago UCLA researchers have launched a new clinical trial that uses a hormone suppresser commonly used
Biotechnology cancer Clinical Trials Immunotherapies Boost immune cells’ ability to kill cancer using “Backpacks”? By Staff Reports 1 year ago Macrophages are immune cells that patrol the body looking for potential threats like viruses, bacteria,
Biotechnology Clinical Trials Coronavirus drug development rare diseases Clinical trial in COVID-19 patients tests anti-inflammatory drug developed 25 years ago at Scripps Research By Staff Reports 1 year ago An anti-inflammatory drug developed at Scripps Research 25 years ago is now being tested as
Clinical Trials Coronavirus rare diseases Penn Launches Clinical Trial to Evaluate Hydroxychloroquine to Treat, Prevent COVID-19 By Staff Reports 2 years ago A new trial led by the Perelman School of Medicine at the University of Pennsylvania
Biotechnology cancer Immunotherapies Immunotherapy effective in metastatic prostate cancers with specific markers of immune activation By Staff Reports 2 years ago Although metastatic castration-resistant prostate cancer (mCRPC) typically has limited response to immunotherapy, a subset of
Biotechnology Coronavirus Infectious Diseases Prescriptions Research & Discovery Vaccines Patients with More Severe Forms of Coronavirus Disease Could Offer Clues to Treatment By Staff Reports 2 years ago Hundreds of clinicians worldwide are banding together in an effort to study some types of severe cases
Biotechnology Clinical Trials Coronavirus Infection Control Infectious Diseases UC San Diego Partners with 5 Leading Diagnostics Manufacturers to Boost COVID-19 Testing By Staff Reports 2 years ago Partnering with five leading in vitro diagnostics manufacturers, an interdisciplinary team of scientists and physicians
Biotechnology cancer Clinical Trials Immunotherapies Vaccines John Theurer Cancer Center Launches Clinical Trial of Personalized Cancer Vaccine Using New Gene-Based Technology for High-Risk Melanoma By Staff Reports 2 years ago John Theurer Cancer Center at Hackensack University Medical Center is the only site in New
Biotechnology Clinical Trials Uncategorized New drug that could aid earlier MS diagnoses approved by FDA for first human clinical trials By Staff Reports 2 years ago A new drug that could make it easier for doctors to diagnose multiple sclerosis (MS)
Biotechnology cancer Clinical Trials drug development New drug shows encouraging survival in pancreatic cancer By Staff Reports 2 years ago A clinical trial testing a new drug in pancreatic cancer had promising initial results, report